Evidence map›Paper›PMID 29379661›Full record

ArticleTurkish journal of obstetrics and gynecology2017

Role of positron emission tomography-computed tomography in endometrial cancer.

Evrim Erdemoğlu, Sevim Süreyya Çerçi, Ebru Erdemoğlu, Yakup Yalçın, Burak Tatar

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of obstetrics and gynecology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Evrim ErdemoğluSüleyman Demirel University Faculty of Medicine, Department of Gynecologic Oncology, Isparta, Turkey.
Sevim Süreyya ÇerçiSüleyman Demirel University Faculty of Medicine, Department of Nuclear Medicine, Isparta, Turkey.
Ebru ErdemoğluMaternity Hospital, Clinic of Obstetrics and Gynecology, Isparta, Turkey.
Yakup YalçınSüleyman Demirel University Faculty of Medicine, Department of Gynecologic Oncology, Isparta, Turkey.
Burak TatarSüleyman Demirel University Faculty of Medicine, Department of Gynecologic Oncology, Isparta, Turkey.
Süleyman Demirel University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe efficacy of preoperative MATERIALS AND

methodsThirty patients with endometrial cancer underwent preoperative

resultsThe mean primary tumor diameter was reported smaller in PET-CT and the effect size of PET-CT was -0.60. The kappa value was 0.06 for myometrial invasion. Pelvic lymph node metastasis was reported in 22.2% of patients in PET-CT. However, 3.7% of patients had pelvic lymph node metastasis. The kappa value for pelvic lymph node metastasis was 0.23, and sensitivity, specificity, and positive and negative predictive values were 100%, 80.7%, 16.6%, and 100%, respectively. Paraaortic lymph node metastasis in PET-CT was suspected in 10%. However, paraaortic lymph node metastasis was found in 6.7% in histopathologic analyses. The kappa value was 0.15. The sensitivity, specificity, and positive and negative predictive values of PET-CT for detecting paraaortic lymph node metastases were 100%, 93.7%, 66.6%, and 100%, respectively. Myometrial invasion and tumor diameter were the only important prognostic factors affecting SUV

conclusionAccording to our results, PET-CT has a limited role and diagnostic efficacy in endometrial cancer. The indications of FDG/PET-CT in endometrium cancer should be studied further and revised.

Indexed as

diagnosisEndometrial cancermaximum standardized uptake valuepositron emission tomographyprognostic factors

Identifiers

PMID29379661
PMCPMC5780562
OpenAlexW2777933501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.